5 tips to reduce the liability risk of prescribing GLP-1s
An action plan for physicians to protect themselves against malpractice litigation related to medications like Ozempic.
As a specialized medical malpractice broker, I am focused on protecting my physician and surgeon clients from the imminent surge of weight loss drug-related malpractice claims. In this article, we give five tips for physicians to protect themselves from claims related to glucagon-like peptide-1 (GLP-1) medications like Ozempic.
Max Schloemann is the founder of MEDPLI Professional Liability Insurance
Recent Videos
Related Content
